Cargando…
Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain
Breastfeeding mothers were excluded from the clinical trials conducted for vaccines against SARS-CoV-2. Since the start of the vaccination, some doubts have arisen regarding its compatibility with breastfeeding. The aim of this study was to analyse the presence of anti-SARS-CoV-2 antibodies in breas...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393848/ https://www.ncbi.nlm.nih.gov/pubmed/34444579 http://dx.doi.org/10.3390/ijerph18168831 |
_version_ | 1783743817813327872 |
---|---|
author | Lechosa-Muñiz, Carolina Paz-Zulueta, María Mendez-Legaza, Jose Manuel Irure-Ventura, Juan Cuesta González, Rocío Calvo Montes, Jorge López-Hoyos, Marcos Llorca, Javier Cabero-Pérez, María Jesús |
author_facet | Lechosa-Muñiz, Carolina Paz-Zulueta, María Mendez-Legaza, Jose Manuel Irure-Ventura, Juan Cuesta González, Rocío Calvo Montes, Jorge López-Hoyos, Marcos Llorca, Javier Cabero-Pérez, María Jesús |
author_sort | Lechosa-Muñiz, Carolina |
collection | PubMed |
description | Breastfeeding mothers were excluded from the clinical trials conducted for vaccines against SARS-CoV-2. Since the start of the vaccination, some doubts have arisen regarding its compatibility with breastfeeding. The aim of this study was to analyse the presence of anti-SARS-CoV-2 antibodies in breast milk and serum (IgG and IgA) of vaccinated breastfeeding women. The main variables of the observational study were: adverse related events after vaccination and determination of the presence of IgG and IgA isotypes antibodies in serum and in breast milk of vaccinated women against the SARS-CoV-2 antigens. Results: 110 breastfeeding mothers were included; 70 women (63.6%) were vaccinated with two doses of BNT162b2, 20 women (18.2%) with two doses of mRNA-1273, and 20 women (18.2%) with a single dose of ChAdOx1-S. Regarding adverse reactions and vaccine safety, 38 women had no adverse reactions; 20 (18.2%) had general malaise or adenopathies; 10 (9.1%) had a headache; and 7 (6.4%) had fever. When analysing IgG antibodies, significantly higher levels of antibodies were found in serum and breast milk from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (p < 0.001 and p = 0.001, respectively). Analysing IgA antibodies, significant differences were found when comparing mean values in serum from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (0.12, 0.16, and 0.02, respectively; p < 0.001) and breast milk of mothers vaccinated when comparing BNT16b2 vs. ChAdOx1-S. All vaccinated breastfeeding mothers had serum anti-S1 IgG antibodies in response to vaccination against SARS-CoV-2, regardless of the commercial vaccine administered. Conclusions: the anti-SARS-CoV-2 vaccines were well tolerated by the mothers and the breastfed infant. In addition, breastfeeding mothers offer their infants IgA and IgG isotype antibodies directed against SARS-CoV-2 protein S in breast milk. |
format | Online Article Text |
id | pubmed-8393848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83938482021-08-28 Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain Lechosa-Muñiz, Carolina Paz-Zulueta, María Mendez-Legaza, Jose Manuel Irure-Ventura, Juan Cuesta González, Rocío Calvo Montes, Jorge López-Hoyos, Marcos Llorca, Javier Cabero-Pérez, María Jesús Int J Environ Res Public Health Article Breastfeeding mothers were excluded from the clinical trials conducted for vaccines against SARS-CoV-2. Since the start of the vaccination, some doubts have arisen regarding its compatibility with breastfeeding. The aim of this study was to analyse the presence of anti-SARS-CoV-2 antibodies in breast milk and serum (IgG and IgA) of vaccinated breastfeeding women. The main variables of the observational study were: adverse related events after vaccination and determination of the presence of IgG and IgA isotypes antibodies in serum and in breast milk of vaccinated women against the SARS-CoV-2 antigens. Results: 110 breastfeeding mothers were included; 70 women (63.6%) were vaccinated with two doses of BNT162b2, 20 women (18.2%) with two doses of mRNA-1273, and 20 women (18.2%) with a single dose of ChAdOx1-S. Regarding adverse reactions and vaccine safety, 38 women had no adverse reactions; 20 (18.2%) had general malaise or adenopathies; 10 (9.1%) had a headache; and 7 (6.4%) had fever. When analysing IgG antibodies, significantly higher levels of antibodies were found in serum and breast milk from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (p < 0.001 and p = 0.001, respectively). Analysing IgA antibodies, significant differences were found when comparing mean values in serum from mothers vaccinated with BNT162b2 or mRNA-1273 vs. ChAdOx1-S (0.12, 0.16, and 0.02, respectively; p < 0.001) and breast milk of mothers vaccinated when comparing BNT16b2 vs. ChAdOx1-S. All vaccinated breastfeeding mothers had serum anti-S1 IgG antibodies in response to vaccination against SARS-CoV-2, regardless of the commercial vaccine administered. Conclusions: the anti-SARS-CoV-2 vaccines were well tolerated by the mothers and the breastfed infant. In addition, breastfeeding mothers offer their infants IgA and IgG isotype antibodies directed against SARS-CoV-2 protein S in breast milk. MDPI 2021-08-21 /pmc/articles/PMC8393848/ /pubmed/34444579 http://dx.doi.org/10.3390/ijerph18168831 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lechosa-Muñiz, Carolina Paz-Zulueta, María Mendez-Legaza, Jose Manuel Irure-Ventura, Juan Cuesta González, Rocío Calvo Montes, Jorge López-Hoyos, Marcos Llorca, Javier Cabero-Pérez, María Jesús Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain |
title | Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain |
title_full | Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain |
title_fullStr | Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain |
title_full_unstemmed | Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain |
title_short | Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain |
title_sort | induction of sars-cov-2-specific igg and iga in serum and milk with different sars-cov-2 vaccines in breastfeeding women: a cross-sectional study in northern spain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393848/ https://www.ncbi.nlm.nih.gov/pubmed/34444579 http://dx.doi.org/10.3390/ijerph18168831 |
work_keys_str_mv | AT lechosamunizcarolina inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain AT pazzuluetamaria inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain AT mendezlegazajosemanuel inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain AT irureventurajuan inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain AT cuestagonzalezrocio inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain AT calvomontesjorge inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain AT lopezhoyosmarcos inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain AT llorcajavier inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain AT caberoperezmariajesus inductionofsarscov2specificiggandigainserumandmilkwithdifferentsarscov2vaccinesinbreastfeedingwomenacrosssectionalstudyinnorthernspain |